Profilo
Nicholas Vlahakis worked as the Chief Medical Officer at CohBar, Inc. in 2022-2023.
Prior to that, he was the Vice President & Head of Clinical Development at Global Blood Therapeutics, Inc. and the Vice President & Head of Respiratory Disease at Unity Biotechnology, Inc. Mr. Vlahakis holds a doctorate degree from the University of Adelaide.
Precedenti posizioni note di Nicholas Vlahakis
| Società | Posizione | Fine |
|---|---|---|
| COHBAR, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2023 |
| UNITY BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Nicholas Vlahakis
| University of Adelaide | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| COHBAR, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Nicholas Vlahakis
